Tools

Results from the Regulation of Coagulation in Orthopaedic Surgery to Prevent Deep Vein Thrombosis and Pulmonary Embolism 4 (RECORD4) trial… »   

A warning of teratogenicity, or abnormal development, isn’t enough for one antiseizure medication: the Food and Drug Administration’s (FDA) Pediatric… »   

FDA announces advisory committee reform, supports adaptive trial designs; HHS report criticizes FDA postmarketing study policies

In response to criticism… »   

Danish pharmaceutical firm H. Lundbeck A/S (LUN.KO) said late Thursday the US Food and Drug Administration (FDA) has requested more… »   

A Food and Drug Administration panel said Wednesday Seroquel was “acceptably safe” and effective to treat schizophrenia in adolescents.

Seroquel,… »   

Swiss drugmaker Roche Holding AG is no longer selling its acne drug Accutane (generic name: isotretinoin) as it has reached… »   

A 10th patient taking Tysabri, known generically as natalizumab, has developed a potentially deadly brain infection since the multiple… »   

A pioneering treatment for genetic cancers which could help thousands of patients is being developed by British scientists.

The drug,… »   

Europe’s drug watchdog has recommended a priority access system to deal with a shortage of two top-selling drugs for… »   

French drugmaker Sanofi-Aventis defended its blockbuster Lantus drug on Thursday after an analyst note raised concerns over the diabetes drug’s… »